Bridgeway Capital Management’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Bridgeway Capital Management’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-87,856	Closed	-$2.46M	–	1442
2019 Q3	$2.46M	Hold	87,856	–	–	0.03%	423
2019 Q2	$1.24M	Sell	87,856 -30,000	-25%	-$285K	0.02%	664
2019 Q1	$1.05M	Buy	+117,856	New	+$957K	0.01%	751

Bridgeway Capital Management's DOVA Position: Q4 2019 in Review

Bridgeway Capital Management sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 87,856 shares — an estimated $2.46M sold.

Bridgeway Capital Management first reported a position in DOVA in Q1 2019 and held it in 3 quarters. The position peaked at $2.46M in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Bridgeway Capital Management reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Bridgeway Capital Management sold 87,856 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $2.46M.
Bridgeway Capital Management first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Bridgeway Capital Management's Dova Pharmaceuticals, Inc. Common Stock position peaked at $2.46M in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Bridgeway Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.